NURECA
Back to All Ratios
|
NURECA Last 5 Year Fixed Capital/Sales History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Fixed Capital/Sales(x) | 0.11 | 0.10 | 0.03 | 0.01 | 0.01 |
What is the latest Fixed Capital/Sales ratio of NURECA ?
Year | Fixed Capital/Sales |
---|---|
Mar2024 | 0.11 |
Mar2023 | 0.10 |
Mar2022 | 0.03 |
Mar2021 | 0.01 |
Mar2020 | 0.01 |
How is Fixed Capital/Sales of NURECA Trending?
Years | Fixed Capital/Sales | % Change | |
---|---|---|---|
Mar2024 | 0.11 | 10.00 | |
Mar2023 | 0.1 | 233.33 | |
Mar2022 | 0.03 | 200.00 | |
Mar2021 | 0.01 | 0.00 | |
Mar2020 | 0.01 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Fixed Capital/Sales ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹281.1 Cr | -2.5% | 2.5% | -22.9% | Stock Analytics | |
POLY MEDICURE | ₹26,321.9 Cr | -8.9% | 0.3% | 74.6% | Stock Analytics | |
PREVEST DENPRO | ₹686.9 Cr | -5.5% | 5.9% | 37.7% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | -2.5% |
2.5% |
-22.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses